Heart Failure Infographic

Heart Failure Infographic

Heart Failure Infographic makes Heart Failure clearer for everyone Heart failure is a syndrome caused by many different reasons. We have produced this heart failure infographic to help people understand – What it is What are the common symptoms of heart failure What are the common causes of heart failure Some facts and figures around […]

Paul Heesom, Warrington Businessman, Awarded Pumping Marvellous Fundraiser of the Year 2017

Paul Heesom, Warrington Businessman, Awarded Fundraiser of the Year 2017

The Pumping Marvellous Foundation, the UK’s Heart Failure Charity Recognise the Impact of One Man’s Contribution to People Living with Heart Failure Paul Heesom, Warrington Businessman, Awarded Fundraiser of the Year 2017 Warrington, Cheshire, Thursday 7th December 2017 – The Management Team from The Pumping Marvellous Foundation paid a surprise visit to Paul Heesom’s Gents […]

Roy Award Recipient Cardiologist Dr Lisa Anderson

Marvellous Awards 2018 Tooting Cardiologist Wins Roy Award

Heart Failure Health Care Professional recognised for marvellous quality of care by the UK’s Heart Failure charity. The Pumping Marvellous Foundation awards “THE ROY AWARD” for outstanding contribution to Heart Failure services. Dr Lisa Anderson Heart Failure Cardiologist based at St George’s University Hospitals Foundation Trust, Tooting – Wins National Roy Award Preston, Lancashire, December […]

Marvellous Awards 2018 - Heart Failure specialists recognised

Marvellous Awards 2018 – Heart Failure specialists recognised

Marvellous Heart Failure Awards 2018 Heart Failure Health Care Professionals recognised for marvellous quality of care by the UK’s Heart Failure charity. The Pumping Marvellous Foundation awards UK Health Care Professionals for being simply marvellous. Preston, Lancashire, December 2017 – Health Care Professionals throughout the UK have been recognised and honoured by patients for their exceptional […]

Earlier Access to New Therapies in the NHS

Earlier Access to New Therapies in the NHS PATIENTS TO GET BREAKTHROUGH TECHNOLOGIES AND TREATMENTS UP TO FOUR YEARS EARLIER THROUGH NEW ACCELERATED ACCESS SCHEME Does this mean earlier access? – A new, fast-track route into the NHS for “breakthrough” medicines and technologies has been announced by the Government in a bid to dramatically speed […]

heart failure's decade?

Heart Failure’s Decade?

Is this Heart Failure’s Decade? Heart Failure has been the classic “Cinderella Syndrome”, under invested, under resourced. The vast majority of the public don’t know what it is. Until the Pumping Marvellous Foundation, formed in 2013 as a registered charity, there has never been a successful orchestrated attempt to advocate for the patient. Naturally you […]

NIQOR National Heart Failure Audit

More Patients than Ever Surviving Heart Failure, National Audit Finds

More patients than ever surviving heart failure following key improvements, audit finds Acute heart failure necessitating hospital admission is a life threatening condition. The quality of care including specialist involvement during an admission, determines the immediate and long-term outcomes including likelihood of survival. Yet while the audit reports several improvements, it also found that the […]

Pericytes Potential to Reverse Heart Damage

Pericytes Potential to Reverse Heart Damage

New pericytes discovery could reverse tissue damage caused by heart attacks A new discovery by University of Bristol scientists helps to explain how cells which surround blood vessels, called pericytes, stimulate new blood vessels to grow with the hormone ‘leptin’ playing a key role. Leptin is produced by fat cells which helps to regulate energy […]

Canakinumab Drug Phase III Study Reducing Heart Attacks

Canakinumab Drug Phase III Study Reducing Heart Attacks

Novartis Phase III study shows ACZ885 (canakinumab) reduces cardiovascular risk in people who survived a heart attack Phase III CANTOS study met the primary endpoint, a composite of heart attack, stroke and cardiovascular death, showing that ACZ885 (canakinumab) in combination with standard of care therapy reduces cardiovascular risk in people with a prior heart attack […]

1 2 3 7